Markets

Ironwood Pharmaceuticals Appoints Tammi Gaskins CEO, Effective Jan. 1, 2027

Oct 16, 2026 · 07:32 AM ET· updated 57m ago

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today announced that its

Why It Matters

Ironwood Pharmaceuticals got a new leader starting in January 2027. When companies switch CEOs, watch to see if they change direction or keep doing well.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

IRWD3.77

+0.17 (+4.72%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.